OS-9 and GRP94 deliver mutant α1-antitrypsin to the Hrd1–SEL1L ubiquitin ligase complex for ERAD

JC Christianson, TA Shaler, RE Tyler, RR Kopito - Nature cell biology, 2008 - nature.com
JC Christianson, TA Shaler, RE Tyler, RR Kopito
Nature cell biology, 2008nature.com
Terminally misfolded or unassembled proteins in the early secretory pathway are degraded
by a ubiquitin-and proteasome-dependent process known as ER-associated degradation
(ERAD). How substrates of this pathway are recognized within the ER and delivered to the
cytoplasmic ubiquitin-conjugating machinery is unknown. We report here that OS-9 and
XTP3-B/Erlectin are ER-resident glycoproteins that bind to ERAD substrates and, through
the SEL1L adaptor, to the ER-membrane-embedded ubiquitin ligase Hrd1. Both proteins …
Abstract
Terminally misfolded or unassembled proteins in the early secretory pathway are degraded by a ubiquitin- and proteasome-dependent process known as ER-associated degradation (ERAD). How substrates of this pathway are recognized within the ER and delivered to the cytoplasmic ubiquitin-conjugating machinery is unknown. We report here that OS-9 and XTP3-B/Erlectin are ER-resident glycoproteins that bind to ERAD substrates and, through the SEL1L adaptor, to the ER-membrane-embedded ubiquitin ligase Hrd1. Both proteins contain conserved mannose 6-phosphate receptor homology (MRH) domains, which are required for interaction with SEL1L, but not with substrate. OS-9 associates with the ER chaperone GRP94 which, together with Hrd1 and SEL1L, is required for the degradation of an ERAD substrate, mutant α1-antitrypsin. These data suggest that XTP3-B and OS-9 are components of distinct, partially redundant, quality control surveillance pathways that coordinate protein folding with membrane dislocation and ubiquitin conjugation in mammalian cells.
nature.com